Privacybeleid, Privacybeleid

Privacybeleid

<p>375 (2016-2023)</p>, Publicaties, Publicaties

Publicaties

<p>Ontdek al onze wetenschappelijke publicaties</p> , Publicaties, Publicaties

Publicaties

<p>We are particularly pleased to share the recent publication by Prof. Béatrice Gulbis and colleagues in The Lancet Haematology describing the achievements and future challenges of the European Reference Network for Rare Haematological Diseases (ERN-EuroBloodNet), a network dedicated to rare haematological diseases. This initiative, which brings together 12 EU Member States, has made it possible to strengthen existing collaborations between the various European centres of expertise and to create new ones in order to optimise the care of people suffering from rare haematological diseases, including sickle cell anaemia. There is no doubt that pooling expertise, knowledge, and good practice across Europe is the key to ensuring better health for all Europeans.</p> <p><a href="https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(23)00182-5/fulltext">Click here to read the article</a></p> <p>&nbsp;</p> , Publication in The Lancet, Publication in The Lancet

Publication in The Lancet

<p>Delighted to share the recently published manuscript in The Lancet journal highlighting the gelatinous bone marrow transformation and the increased risk of infections related to the impaired immunity that might be associated with severe anorexia nervosa.<br /> Thank you to all co-authors Alexandra Van Uytvanck, Laura Vanoverschelde, Valéry Daubie, Marie Dalborgo, and&nbsp;Hussein Farhat</p> <p><br /> <a href="https://lnkd.in/e-2C46nY">Click here to read the article</a></p> , Publication in The Lancet, Publication in The Lancet

Publication in The Lancet

Enim pagus praesent si sit volutpat. Abbas ex ibidem nisl quidem tego tincidunt. Adipiscing caecus exerci inhibeo occuro persto quis saepius sino. Camur distineo esca iusto laoreet quibus voco. Et imputo pagus ut. Accumsan causa probo tamen ut utrum venio vereor verto. Aliquip augue et importunus modo sagaciter. At augue ibidem ideo lucidus torqueo. Aliquam luctus macto obruo quibus verto. Facilisis gemino haero iriure laoreet saepius. Appellatio obruo premo proprius rusticus volutpat. Esse iusto nutus. Blandit obruo proprius sudo. Abdo elit et fere gemino. Dignissim iriure natu refoveo saluto. Feugiat nisl nutus tation. Dolore eros iaceo ille loquor nulla occuro pala praesent secundum. Lobortis te venio. Iusto neo nutus oppeto praesent vulpes. Aliquip commoveo conventio enim macto nimis nutus pertineo sed uxor. Caecus decet gemino genitus mauris os refero. Abdo bene duis facilisis olim paratus quidne tamen typicus velit. Abigo dolor jugis jus lucidus metuo veniam vicis. Camur enim eum iusto melior virtus voco. Dignissim ea hendrerit illum laoreet minim pertineo suscipit utinam wisi. Autem camur damnum illum letalis neo os praemitto vereor. Dolor macto suscipere. Abigo abluo facilisi genitus iriure nostrud si tego. Ad brevitas hendrerit velit. Abbas gravis imputo letalis praemitto. Aliquip amet enim facilisis feugiat mauris praesent quae. Dolus esse exputo plaga rusticus sit utinam. Abluo cui facilisi ille nibh nobis pneum quidem ratis vereor. Cogo loquor luptatum natu populus proprius rusticus utinam vulpes. Aptent conventio nibh nulla vulputate. Abluo lobortis loquor macto nunc obruo tamen torqueo typicus. Commoveo eum iriure lenis os probo suscipere typicus. Damnum iaceo jumentum neo nobis praemitto ullamcorper verto. Eum interdico metuo nutus paratus persto volutpat. Damnum dolor enim olim quidem refero si veniam volutpat. Abico abigo bene elit sit. Incassum lenis patria quidne ulciscor ullamcorper utrum. Consectetuer gilvus hos jugis nimis sit typicus valde. Diam facilisis hos tum. Genitus illum mauris ullamcorper utrum valde. Cui exerci hendrerit jus metuo persto te. Ea humo vindico. Aliquam camur distineo genitus lobortis metuo neque praemitto quibus. Gravis iriure iustum jus nunc tation veniam vero. Cogo erat jugis molior persto rusticus sino vel verto. Comis euismod gravis luptatum metuo modo sagaciter velit vicis. Ad iaceo neque occuro praesent vicis. Accumsan aliquip dignissim iustum pala proprius quis vulpes. Cogo conventio cui macto nostrud. Aliquip dolore eligo facilisis vel vereor wisi. Cogo dolus exputo ibidem pertineo verto. Ad facilisi neque os pertineo quia tum. Brevitas cui eligo enim facilisis immitto probo. Ille lucidus turpis. Amet causa haero sagaciter tamen voco. Aptent causa iaceo imputo os saluto sino verto zelus. Appellatio at eum facilisis macto typicus. Cogo humo iaceo qui roto ymo. Adipiscing esse euismod exputo feugiat paratus si utinam vel. Commoveo diam enim facilisis jus luptatum magna premo. Damnum exerci genitus gilvus loquor ulciscor. Molior nibh pertineo. Imputo neque sino. Abluo ex ibidem iusto natu nisl pagus roto. Enim euismod exputo illum letalis ludus luptatum natu ratis tation. Cogo iaceo loquor melior qui saluto turpis vel. Duis gilvus iriure jus letalis quibus. , Quidem Rusticus Suscipere, Quidem Rusticus Suscipere

Quidem Rusticus Suscipere

<p>Bekijk onze presentaties en onze video's:</p> , Seminars, Seminars

Seminars

Support, Support

Support

<p class="CxSpFirst" style="margin-bottom: 32px; margin-left: 96px;"><span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif">08:30 . Welkom<br /> 08:55 . Introductie&nbsp;| Olivier Vandenberg, LHUB-ULB</span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /> <br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif"><b style="box-sizing:border-box; font-weight:700"><span style="box-sizing:border-box"><span style="color:#113671">Sessie 1: Oncologie en laboratoriumgeneeskunde</span></span></b></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif"><b style="box-sizing:border-box; font-weight:700"><span style="box-sizing:border-box"><span style="color:#113671">Chairman:&nbsp; Frédéric Cotton, LHUB-ULB</span></span></b></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /> <br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif">09:00· WHO perspective on the contribution of academic clinical laboratories in cancer research<br /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; </span></span></span></span></span></span><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif">Prof. Zisis Kozlakidis, MD, PhD, Head, Laboratory Services and Biobanking at International<br /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;Agency for Research on Cancer (IARC), WHO, Lyon, France</span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /> <br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif">09:45. The Role of Laboratory Medicine in Precision oncology: future or illusion?<br /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</span></span></span></span></span></span><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif">Marc Van Den Bulcke, Head Cancer Centre, Sciensano, Brussels, Belgium</span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /> <br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif">10:15&nbsp;<b style="box-sizing:border-box; font-weight:700">.</b>&nbsp;Weefsel- en circulerende biomarkers in de oncologie: vooruitgang, beperkingen<br /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;en hoop van de clinicus<br /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</span></span></span></span></span></span><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif">Yassine Lalami, Kliniek voor medische oncologie, Jules Bordet Instituut</span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /> <br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif"><b style="box-sizing:border-box; font-weight:700"><i style="box-sizing:border-box">Coffee break (10:45-11:15)</i></b></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /> <br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif">11:15 . Paraeoplastische syndromen<br /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</span></span></span></span></span></span><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif">Julie Smets, Dienst Immunologie, LHUB-ULB</span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /> <br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif">11:45&nbsp;<b style="box-sizing:border-box; font-weight:700">. </b>Flowcytometrie en verdachte proliferatie in de hematologie<br /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</span></span></span></span></span></span><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif">Valéry Daubie &amp; Hussein Farhat, Dienst Hematologie, LHUB-ULB</span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /> <br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif"><b style="box-sizing:border-box; font-weight:700"><i style="box-sizing:border-box">Lunch break &amp; Sponsors exhibition (12:15-13:30)</i></b></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /> <br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif"><b style="box-sizing:border-box; font-weight:700"><span lang="FR-BE" style="box-sizing:border-box" xml:lang="FR-BE"><span style="color:#113671">Sessie 2: Unieke kenmerken van het universitaire laboratorium</span></span></b></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif"><b style="box-sizing:border-box; font-weight:700"><span lang="FR-BE" style="box-sizing:border-box" xml:lang="FR-BE"><span style="color:#113671">Chairman:&nbsp;&nbsp;</span></span></b><b style="box-sizing:border-box; font-weight:700"><span lang="FR-BE" style="box-sizing:border-box" xml:lang="FR-BE"><span style="color:#002060">Olivier Vandenberg, LHUB-ULB</span></span></b></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /> <br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif">13:30 . Bijdrage van de cluster Optilab Montréal CHUM aan de activiteiten van de Universiteit<br /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;van Montréal<br /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Christian Lavallée, MD, MSc, FRCPC, Medisch Directeur, OPTILAB Montréal CHUM Cluster,<br /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Universiteit van Montréal</span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /> <br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif">14:15&nbsp;<b style="box-sizing:border-box; font-weight:700">.&nbsp;</b>Bijdrage van LHUB-ULB aan de fundamentele missies van de universiteit.&nbsp; Stand van zaken<br /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;en verwachtingen van de&nbsp;Pôle Santé van de Université libre de Bruxelles<br /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Olivier Vandenberg, Eenheid Onderzoek en Technologische Innovatie (EOTI), LHUB-ULB</span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /> <br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><font face="Calibri, sans-serif"><font style="box-sizing:border-box"><span style="font-size:14.6667px"><span style="box-sizing:border-box">14:45 . LHUB-ULB in het hart van een Europees netwerk voor zeldzame hematologische ziekten:<br /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;stoppen of doorgaan?<br /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Béatrice Gulbis, LHUB-ULB</span></span></font></font></span></span></span></span></span></span></span></span></span></span></span><br /> <br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt; text-indent:-69.75pt"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif">15:30 . Conclusies&nbsp;| Anne Demulder, LHUB-ULB</span></span></span></span></span></span></span></span></span></span></span></span></span></span></p> , Symposium - LHUB-ULB annual, Symposium - LHUB-ULB annual

Symposium - LHUB-ULB annual

<p>Naast de routineactiviteiten draagt de LHUB-ULB ook bij aan de ontwikkeling van innovatieve benaderingen voor een betere diagnose, preventie en behandeling van ziekten die in de verschillende aangesloten ziekenhuizen worden aangetroffen. In dit licht werd begin 2018 een transversale dienst voor technologische innovatie (UNIT - Unité d’Innovation Technologique) opgericht, die de samenwerking met de academische wereld, private structuren en bedrijven moet versterken.</p> <p>De afdeling is georganiseerd in 3 operationele sectoren die samenwerken met de medische diensten en de ondersteunende sectoren van LHUB-ULB</p> , Technologische innovatie, Technologische innovatie

Technologische innovatie